MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1.
暂无分享,去创建一个
H. Zhang | Wei-dong Xu | P. Cheng | Ming Li | Zimin Wang | Yifan Kang | Hao Tang | D. Tong | Fang Ji | Yang Wang | Cheng Li | Zhiwei Wang
[1] Wei Zhang,et al. microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor. , 2012, Oncology reports.
[2] Junfeng Zhu,et al. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. , 2012, The American journal of pathology.
[3] Z. Duan,et al. MicroRNA Involvement in Osteosarcoma , 2012, Sarcoma.
[4] Baoan Ma,et al. MicroRNA-34a Inhibits the Proliferation and Metastasis of Osteosarcoma Cells Both In Vitro and In Vivo , 2012, PloS one.
[5] E. Kleinerman,et al. miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. , 2012, Cancer research.
[6] Jia Chen,et al. miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3. , 2011, Biochemical and biophysical research communications.
[7] L. Xiaoyun,et al. MicroRNA-21 is involved in osteosarcoma cell invasion and migration , 2011, Medical oncology.
[8] P. S. Mitchell,et al. MicroRNA-138 Modulates DNA Damage Response by Repressing Histone H2AX Expression , 2011, Molecular Cancer Research.
[9] Li Lin,et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. , 2011, Cancer cell.
[10] N. Seki,et al. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer , 2011, British Journal of Cancer.
[11] Masayuki Kano,et al. miR‐145, miR‐133a and miR‐133b: Tumor‐suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma , 2010, International journal of cancer.
[12] H. Zhang,et al. microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. , 2010, Oncology reports.
[13] H. Lodish,et al. Distinct roles for miR‐1 and miR‐133a in the proliferation and differentiation of rhabdomyosarcoma cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] W. De,et al. Functional and biological analysis of Bcl-xL expression in human osteosarcoma. , 2010, Bone.
[15] P. Gunaratne,et al. Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. , 2010, Cancer research.
[16] D. Glavač,et al. MicroRNAs miR-1, miR-133a, miR-133b and miR-208 Are Dysregulated in Human Myocardial Infarction , 2009, Cardiology.
[17] G. Camussi,et al. Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways , 2009, Molecular Cancer.
[18] J. Yun,et al. Effects of MicroRNA‐29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma , 2009, Hepatology.
[19] Lijun Liu,et al. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples. , 2009, Biochemical and biophysical research communications.
[20] Y. Wang,et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells , 2009, Oncogene.
[21] Jian-Rong Yang,et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. , 2009, Cancer research.
[22] G. Stein,et al. A microRNA signature for a BMP2-induced osteoblast lineage commitment program , 2008, Proceedings of the National Academy of Sciences.
[23] N. Rajewsky,et al. Widespread changes in protein synthesis induced by microRNAs , 2008, Nature.
[24] Emelyn H. Shroff,et al. Bcl-2 family members regulate anoxia-induced cell death. , 2007, Antioxidants & redox signaling.
[25] G. Bacci,et al. Primary bone osteosarcoma in the pediatric age: state of the art. , 2006, Cancer treatment reviews.
[26] Harvey F Lodish,et al. Myogenic factors that regulate expression of muscle-specific microRNAs. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[27] Stijn van Dongen,et al. miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..
[28] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.